Natco Pharma Ltd buy melinda
Start price
05.04.18
/
50%
?10.04
Target price
04.11.19
€13.39
Performance (%)
0.00%
End price
04.11.19
-
Summary
This prediction ended on 04.11.19 with a price of -. melinda's BUY prediction for Natco Pharma Ltd closed unchanged from the start price. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Natco Pharma Ltd | - | - | - | - |
iShares Core DAX® | 1.280% | 1.320% | 13.605% | 15.782% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% | 38.434% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% | 6.570% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% | 39.611% |
Comments by melinda for this prediction
In the thread Natco Pharma Ltd diskutieren
SektorPharmazeutika
05 April 2018 09:42 IST
Natco Pharma steigt bei der Markteinführung der ersten generischen Version von Teriflunomid um 3%
Teriflunomid wird von Sanofi-Genzyme unter der Marke AUBAGIO auf dem amerikanischen Markt vertrieben.
Es gibt keinen Handelsplatz